Many more people work very early morning shifts than overnight ones, and a large proportion struggle with excessive ...
News Medical on MSN
Wake-promoting drug improves alertness in early morning shift workers
Many more people work very early morning shifts than overnight ones, and a large proportion struggle with excessive sleepiness from shift work disorder, leading to problems with focus, performance and ...
Mass General Brigham researchers found that solriamfetol helped early morning shift workers with shift work disorder stay more alertMany more people ...
Axsome Therapeutics has reached a settlement agreement with Hetero Labs to resolve a patent dispute related to Hetero Labs’s plans to release a generic of Sunosi, which is a sleep disorder therapy.
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, ...
Axsome Therapeutics, Inc. has three marketed CNS drugs and pipeline potential in Alzheimer's and narcolepsy. Read why AXSM stock is a buy.
It has been about a month since the last earnings report for Axsome Therapeutics (AXSM). Shares have added about 19.2% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Axsome Therapeutics is dedicated to developing and commercializing medicines for conditions affecting the brain and nervous system. Its primary focus is on diseases with limited existing treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results